WILLF (Demant AS) FCF Margin % : 19.30% (As of Dec. 2024)

View and export this data going back to . Start your Free Trial

What is Demant AS FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Demant AS's Free Cash Flow for the six months ended in Dec. 2024 was $307 Mil. Demant AS's Revenue for the six months ended in Dec. 2024 was $1,591 Mil. Therefore, Demant AS's FCF Margin % for the quarter that ended in Dec. 2024 was 19.30%.

As of today, Demant AS's current FCF Yield % is 6.12%.

The historical rank and industry rank for Demant AS's FCF Margin % or its related term are showing as below:

WILLF' s FCF Margin % Range Over the Past 10 Years
Min: 7.64 Med: 10.83 Max: 16.77
Current: 14.66

During the past 13 years, the highest FCF Margin % of Demant AS was 16.77%. The lowest was 7.64%. And the median was 10.83%.

WILLF's FCF Margin % is ranked better than
87.35% of 830 companies
in the Medical Devices & Instruments industry
Industry Median: -4.29 vs WILLF: 14.66

Demant AS FCF Margin % Historical Data

The historical data trend for Demant AS's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Demant AS FCF Margin % Chart

Demant AS Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

FCF Margin %

Get a 7-Day Free Trial

13.41

16.01

8.62

16.77

14.72

Demant AS Semi-Annual Data
	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
FCF Margin %	Get a 7-Day Free Trial															11.73	14.05	19.44	10.05	19.30

Competitive Comparison of Demant AS's FCF Margin %

For the Medical Devices subindustry, Demant AS's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Demant AS's FCF Margin % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Demant AS's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Demant AS's FCF Margin % falls into.

Demant AS FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Demant AS's FCF Margin for the fiscal year that ended in Dec. 2024 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2024 )	/	Revenue (A: Dec. 2024 )
	=	463.487	/	3147.808
	=	14.72 %

Demant AS's FCF Margin for the quarter that ended in Dec. 2024 is calculated as

FCF Margin	=	Free Cash Flow (Q: Dec. 2024 )	/	Revenue (Q: Dec. 2024 )
	=	307.072	/	1591.104
	=	19.30 %

Demant AS FCF Margin % Related Terms

Thank you for viewing the detailed overview of Demant AS's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Demant AS Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Demant AS (OTCPK:WILLF) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

WILYY:USA DEMANc:UK 0RGT:UK DEMANT:Denmark WDH1:Germany DEMA:Austria

Address

Kongebakken 9, Smorum, DNK, 2765

Website

https://www.demant.com

Demant AS is a Denmark-based company engaged in the healthcare industry. The company develops, manufactures and sells products and equipment designed to aid the hearing and communication of individuals. The Group focuses on four business areas: Hearing Devices, including such brands as Bernafon, Oticon, Frontrow, Phonic Ear and Sonic; Hearing Implants, including Oticon Medical; Diagnostic Instruments. The Company operates through more than 90 subsidiaries and associates all around the world. More than 80% of the company's sales come from North America and Europe.